Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization
- PMID: 17438147
- DOI: 10.1161/CIRCULATIONAHA.107.693739
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization
Abstract
Background: Late stent thrombosis (LST) after Cypher and Taxus drug-eluting stent placement has emerged as a major concern. Although the clinical predictors of LST have been reported, specific morphological and histological correlates of LST remain unknown.
Methods and results: From a registry totaling 81 human autopsies of drug-eluting stents, 46 (62 lesions) had a drug-eluting stent implanted >30 days. We identified 28 lesions with thrombus and compared those with 34 of similar duration without thrombosis using computer-guided morphometric and histological analyses. LST was defined as an acute thrombus within a coronary artery stent in place >30 days. Multiple logistic generalized estimating equations modeling demonstrated that endothelialization was the best predictor of thrombosis. The morphometric parameter that best correlated with endothelialization was the ratio of uncovered to total stent struts per section. A univariable logistic generalized estimating equations model of occurrence of thrombus in a stent section versus ratio of uncovered to total stent struts per section demonstrated a marked increase in risk for LST as the number of uncovered struts increased. The odds ratio for thrombus in a stent with a ratio of uncovered to total stent struts per section >30% is 9.0 (95% CI, 3.5 to 22).
Conclusions: The most powerful histological predictor of stent thrombosis was endothelial coverage. The best morphometric predictor of LST was the ratio of uncovered to total stent struts. Heterogeneity of healing is a common finding in drug-eluting stents with evidence of LST and demonstrates the importance of incomplete healing of the stented segment in the pathophysiology of LST.
Comment in
-
Letter by Testa et al regarding article, "Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization".Circulation. 2007 Nov 27;116(22):e549; author reply e550. doi: 10.1161/CIRCULATIONAHA.107.711374. Circulation. 2007. PMID: 18040034 No abstract available.
Similar articles
-
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.J Am Coll Cardiol. 2006 Jul 4;48(1):193-202. doi: 10.1016/j.jacc.2006.03.042. Epub 2006 May 5. J Am Coll Cardiol. 2006. PMID: 16814667
-
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.J Am Coll Cardiol. 2005 Mar 15;45(6):941-6. doi: 10.1016/j.jacc.2004.11.064. J Am Coll Cardiol. 2005. PMID: 15766833 Review.
-
Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results.Chin Med J (Engl). 2010 Apr 5;123(7):778-81. Chin Med J (Engl). 2010. PMID: 20497663
-
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.Circulation. 2009 Feb 10;119(5):680-6. doi: 10.1161/CIRCULATIONAHA.108.803528. Epub 2009 Jan 26. Circulation. 2009. PMID: 19171853 Clinical Trial.
-
Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.J Am Coll Cardiol. 2006 May 16;47(10):2108-11. doi: 10.1016/j.jacc.2005.11.092. Epub 2006 Apr 4. J Am Coll Cardiol. 2006. PMID: 16697331 Review.
Cited by
-
Visualization of Vulnerable Coronary Plaque and Prevention of Plaque Rupture.Juntendo Iji Zasshi. 2024 Jun 15;70(4):260-268. doi: 10.14789/jmj.JMJ24-0011-R. eCollection 2024. Juntendo Iji Zasshi. 2024. PMID: 39431179 Free PMC article.
-
Early vascular healing after neXt-generation drug-eluting stent implantation in Patients with non-ST elevation acute Coronary syndrome: a randomized optical coherence Tomography imaging study (EXPECT).Int J Cardiovasc Imaging. 2024 Oct 12. doi: 10.1007/s10554-024-03258-w. Online ahead of print. Int J Cardiovasc Imaging. 2024. PMID: 39395073
-
Widespread Use of Imaging-Guided PCI in Asia: Time for Extended Application.JACC Asia. 2024 Aug 20;4(9):639-656. doi: 10.1016/j.jacasi.2024.07.003. eCollection 2024 Sep. JACC Asia. 2024. PMID: 39371623 Free PMC article. Review.
-
Assessment of Effectiveness of the Algorithm for Automated Quantitative Analysis of Metallic Strut Tissue Short-Term Coverage with Intravascular Optical Coherence Tomography.J Clin Med. 2024 Jul 25;13(15):4336. doi: 10.3390/jcm13154336. J Clin Med. 2024. PMID: 39124606 Free PMC article.
-
Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy.J Clin Med. 2024 Mar 17;13(6):1730. doi: 10.3390/jcm13061730. J Clin Med. 2024. PMID: 38541955 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
